The article is frequently cited in discussions about the limitations of current ADHD drug therapies, which often lack long-term safety evidence and may be less preferred by parents and clinicians than non-pharmacological alternatives.
The request likely refers to the academic review article published by Katya Rubia in the journal Psychiatry and Clinical Neurosciences in 2022. Article Overview Rubia (2022)
: Using EEG (most common), functional near-infrared spectroscopy (fNIRS), and functional MRI (fMRI). The article is frequently cited in discussions about
: The review evaluates several non-pharmacological treatments, including: functional near-infrared spectroscopy (fNIRS)